Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.
Elger C, Koepp M, Trinka E, Villanueva V, Chaves J, Ben-Menachen E, Kowacs PA, Gil-Nagel A, Moreira J, Gama H, Rocha JF, Soares-da-Silva P. Elger C, et al. CNS Neurosci Ther. 2017 Dec;23(12):961-972. doi: 10.1111/cns.12765. Epub 2017 Oct 13. CNS Neurosci Ther. 2017. PMID: 29030894 Free PMC article.
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P; BIA-2093-301 Investigators Study Group. Elger C, et al. Epilepsia. 2009 Mar;50(3):454-63. doi: 10.1111/j.1528-1167.2008.01946.x. Epub 2009 Feb 21. Epilepsia. 2009. PMID: 19243424 Free article. Clinical Trial.
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
Halász P, Cramer JA, Hodoba D, Członkowska A, Guekht A, Maia J, Elger C, Almeida L, Soares-da-Silva P; BIA-2093-301 Study Group. Halász P, et al. Among authors: elger c. Epilepsia. 2010 Oct;51(10):1963-9. doi: 10.1111/j.1528-1167.2010.02660.x. Epilepsia. 2010. PMID: 20662896 Free article. Clinical Trial.
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.
Gil-Nagel A, Elger C, Ben-Menachem E, Halász P, Lopes-Lima J, Gabbai AA, Nunes T, Falcão A, Almeida L, da-Silva PS. Gil-Nagel A, et al. Among authors: elger c. Epilepsia. 2013 Jan;54(1):98-107. doi: 10.1111/j.1528-1167.2012.03605.x. Epub 2012 Aug 6. Epilepsia. 2013. PMID: 22882018 Free article. Clinical Trial.
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton V, Rogin JB, Krauss G, Abou-Khalil B, Rocha JF, Moreira J, Gama H, Trinka E, Elger CE, Cheng H, Grinnell T, Blum D; Study 301, 302 and 304 Investigators. Biton V, et al. Epilepsy Behav. 2017 Jul;72:127-134. doi: 10.1016/j.yebeh.2017.04.019. Epub 2017 Jun 7. Epilepsy Behav. 2017. PMID: 28575761 Free article.
897 results